Cryoport (CYRX)
Cryoport on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as pharmaceutical preparations.
2.5M
Short interest
settlement 2026-10-15
3.1
Days to cover
-0.3 days vs prior
32.7%
Short share of volume
2026-11-02
645
Fails to deliver
settlement 2026-09-24
Tue 3 Nov
Next earnings
estimated date
-$429K
Insider flow, 90 days
0 buys, 1 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in CYRX is 2,532,755 shares, down 253,759 shares over the last month. Over the last 48 readings it ranged from 1,900,465 shares (15 May 2026) to 3,747,401 shares (14 November 2025). At the reported average volume of 828K shares a day that is 3.1 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/cyrx" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 2,532,755 | +7.2% | 827,871 | 3.06 |
| 2026-09-30 | 2,362,636 | -15.2% | 698,414 | 3.38 |
| 2026-09-15 | 2,786,514 | +2.7% | 477,984 | 5.83 |
| 2026-08-31 | 2,713,665 | +7.9% | 559,096 | 4.85 |
| 2026-08-14 | 2,515,480 | +0.6% | 541,275 | 4.65 |
| 2026-07-31 | 2,499,552 | -0.8% | 618,538 | 4.04 |
| 2026-07-15 | 2,520,691 | +15.7% | 685,406 | 3.68 |
| 2026-06-30 | 2,178,347 | -0.9% | 847,607 | 2.57 |
| 2026-06-15 | 2,197,453 | -5.1% | 971,424 | 2.26 |
| 2026-05-29 | 2,315,640 | +21.9% | 1,057,685 | 2.19 |
| 2026-05-15 | 1,900,465 | -13.7% | 802,757 | 2.37 |
| 2026-04-30 | 2,202,556 | -2.4% | 420,214 | 5.24 |
| 2026-04-15 | 2,256,431 | +4.0% | 443,723 | 5.09 |
| 2026-03-31 | 2,170,635 | -4.1% | 445,148 | 4.88 |
| 2026-03-13 | 2,263,307 | -4.5% | 523,756 | 4.32 |
| 2026-02-27 | 2,368,648 | -8.1% | 268,893 | 8.81 |
| 2026-02-13 | 2,576,726 | -7.9% | 369,385 | 6.98 |
| 2026-01-30 | 2,798,677 | -5.5% | 317,891 | 8.80 |
| 2026-01-15 | 2,963,014 | +0.2% | 367,313 | 8.07 |
| 2025-12-31 | 2,958,058 | -3.5% | 363,482 | 8.14 |
| 2025-12-15 | 3,065,105 | -6.5% | 568,440 | 5.39 |
| 2025-11-28 | 3,277,722 | -12.5% | 598,770 | 5.47 |
| 2025-11-14 | 3,747,401 | +19.4% | 742,923 | 5.04 |
| 2025-10-31 | 3,138,924 | +6.3% | 932,073 | 3.37 |
| 2025-10-15 | 2,951,816 | +5.6% | 477,570 | 6.18 |
| 2025-09-30 | 2,794,880 | +10.9% | 558,559 | 5.00 |
| 2025-09-15 | 2,519,310 | -7.6% | 746,162 | 3.38 |
| 2025-08-29 | 2,725,248 | -0.1% | 419,330 | 6.50 |
| 2025-08-15 | 2,729,040 | -6.1% | 1,604,511 | 1.70 |
| 2025-07-31 | 2,905,756 | +7.7% | 460,061 | 6.32 |
| 2025-07-15 | 2,697,153 | -2.1% | 359,326 | 7.51 |
| 2025-06-30 | 2,755,104 | +13.0% | 712,258 | 3.87 |
| 2025-06-13 | 2,437,721 | -3.1% | 491,934 | 4.96 |
| 2025-05-30 | 2,516,152 | -8.0% | 360,426 | 6.98 |
| 2025-05-15 | 2,734,034 | +3.3% | 503,261 | 5.43 |
| 2025-04-30 | 2,648,061 | +2.1% | 425,378 | 6.23 |
| 2025-04-15 | 2,594,160 | +6.2% | 518,321 | 5.00 |
| 2025-03-31 | 2,443,367 | +9.7% | 566,665 | 4.31 |
| 2025-03-14 | 2,227,901 | +8.9% | 835,533 | 2.67 |
| 2025-02-28 | 2,046,167 | -1.8% | 276,207 | 7.41 |
| 2025-02-14 | 2,082,876 | +3.8% | 223,008 | 9.34 |
| 2025-01-31 | 2,007,584 | +2.2% | 241,716 | 8.31 |
| 2025-01-15 | 1,964,992 | -5.3% | 303,978 | 6.46 |
| 2024-12-31 | 2,075,597 | -5.6% | 250,066 | 8.30 |
| 2024-12-13 | 2,198,722 | -12.1% | 405,814 | 5.42 |
| 2024-11-29 | 2,501,805 | -7.2% | 564,236 | 4.43 |
| 2024-11-15 | 2,696,689 | -7.3% | 488,579 | 5.52 |
| 2024-10-31 | 2,908,718 | +3.2% | 281,009 | 10.35 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of CYRX volume is 32.7%, down 13.5 points over the last five sessions. Over the last 30 readings it ranged from 22.8% (29 October 2026) to 62.0% (2 October 2026). The latest reading is 12.4 points below the 30-session average of 45.1%, on 382K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 125K | 382K | 32.7% | 0 |
| 2026-10-30 | 118K | 211K | 55.9% | 1 |
| 2026-10-29 | 27K | 117K | 22.8% | 0 |
| 2026-10-28 | 52K | 189K | 27.7% | 200 |
| 2026-10-27 | 61K | 155K | 39.6% | 12,983 |
| 2026-10-26 | 77K | 166K | 46.2% | 0 |
| 2026-10-23 | 68K | 154K | 44.3% | 9,711 |
| 2026-10-22 | 134K | 284K | 47.1% | 1,000 |
| 2026-10-21 | 150K | 283K | 53.0% | 10,510 |
| 2026-10-20 | 136K | 284K | 48.1% | 0 |
| 2026-10-19 | 78K | 178K | 44.0% | 0 |
| 2026-10-16 | 84K | 166K | 50.6% | 0 |
| 2026-10-15 | 77K | 208K | 36.9% | 0 |
| 2026-10-14 | 61K | 169K | 35.8% | 205 |
| 2026-10-13 | 63K | 159K | 39.4% | 0 |
| 2026-10-12 | 90K | 213K | 42.0% | 0 |
| 2026-10-09 | 77K | 158K | 48.6% | 0 |
| 2026-10-08 | 206K | 382K | 54.0% | 10 |
| 2026-10-07 | 234K | 475K | 49.3% | 1,800 |
| 2026-10-06 | 138K | 283K | 48.8% | 4 |
| 2026-10-05 | 124K | 270K | 45.7% | 0 |
| 2026-10-02 | 180K | 290K | 62.0% | 0 |
| 2026-10-01 | 180K | 291K | 61.8% | 6,195 |
| 2026-09-30 | 52K | 114K | 45.5% | 468 |
| 2026-09-29 | 81K | 165K | 49.3% | 0 |
| 2026-09-28 | 114K | 257K | 44.3% | 0 |
| 2026-09-25 | 53K | 129K | 40.9% | 0 |
| 2026-09-24 | 117K | 247K | 47.5% | 11,805 |
| 2026-09-23 | 87K | 182K | 47.8% | 0 |
| 2026-09-22 | 89K | 217K | 41.0% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 24 September 2026, the fails-to-deliver balance in CYRX is 645 shares, up 347 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (13 March 2026) to 14,627 shares (20 April 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-24 | 645 | $17.49 | $11K |
| 2026-09-10 | 298 | $15.14 | $5K |
| 2026-08-11 | 964 | $14.82 | $14K |
| 2026-08-07 | 99 | $14.71 | $1K |
| 2026-08-06 | 1,036 | $15.25 | $16K |
| 2026-08-05 | 799 | $15.22 | $12K |
| 2026-08-03 | 387 | $15.09 | $6K |
| 2026-07-30 | 2,050 | $14.93 | $31K |
| 2026-07-29 | 241 | $15.17 | $4K |
| 2026-07-21 | 1 | $15.71 | $16 |
| 2026-07-16 | 100 | $16.57 | $2K |
| 2026-07-08 | 3,448 | $15.06 | $52K |
| 2026-06-16 | 300 | $14.83 | $4K |
| 2026-06-15 | 423 | $14.62 | $6K |
| 2026-06-11 | 38 | $14.77 | $561 |
| 2026-05-22 | 328 | $14.22 | $5K |
| 2026-05-18 | 56 | $13.14 | $736 |
| 2026-05-12 | 100 | $13.17 | $1K |
| 2026-04-22 | 284 | $10.68 | $3K |
| 2026-04-20 | 14,627 | $10.35 | $151K |
| 2026-04-10 | 1,708 | $9.76 | $17K |
| 2026-04-09 | 144 | $9.23 | $1K |
| 2026-03-31 | 122 | $7.89 | $963 |
| 2026-03-23 | 311 | $8.04 | $3K |
| 2026-03-20 | 854 | $8.29 | $7K |
| 2026-03-13 | 1 | $7.72 | $8 |
| 2026-03-10 | 369 | $8.09 | $3K |
| 2026-03-09 | 301 | $8.09 | $2K |
| 2026-03-05 | 11 | $8.74 | $96 |
| 2026-03-03 | 93 | $8.21 | $764 |
Insider trades
SEC Form 4, newest first. JSONInsiders at CYRX reported 1 open-market sell worth $429K in the last 90 days and no open-market buys. Latest filing: SHELTON JERRELL (President, CEO) on 2026-08-11.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-08-11 | SHELTON JERRELL | President, CEO | Sell | 29K | $14.91 | $429K | 1.2M |
| 2026-06-11 | ZECCHINI EDWARD J | Chief Digital and Tech Officer | Exercise or conversion | 34K | $4.80 | $161K | 143K |
| 2026-06-11 | ZECCHINI EDWARD J | Chief Digital and Tech Officer | Sell | 34K | $14.47 | $486K | 110K |
| 2026-06-10 | ZECCHINI EDWARD J | Chief Digital and Tech Officer | Exercise or conversion | 1K | $4.80 | $7K | 111K |
| 2026-06-10 | ZECCHINI EDWARD J | Chief Digital and Tech Officer | Sell | 1K | $15.23 | $21K | 110K |
| 2026-06-08 | Mandalam Ramkumar | Director | Sell | 23K | $15.44 | $358K | 68K |
| 2026-06-05 | HANCOCK DANIEL M | Director | Grant | 10K | $0.00 | $0 | 69K |
| 2026-06-05 | Hariri Robert J | Director | Grant | 10K | $0.00 | $0 | 62K |
| 2026-06-05 | Mandalam Ramkumar | Director | Grant | 10K | $0.00 | $0 | 91K |
| 2026-06-05 | BADDOUR LINDA | Director | Grant | 10K | $0.00 | $0 | 68K |
| 2026-06-04 | STEFANOVICH ROBERT | Chief Financial Officer | Sell | 169K | $16.27 | $2.8M | 110K |
| 2026-04-21 | SHELTON JERRELL | President, CEO | Exercise or conversion | 104K | $1.87 | $194K | 1.2M |
| 2026-04-06 | SHELTON JERRELL | President, CEO | Exercise or conversion | 50K | $1.87 | $94K | 1.1M |
| 2026-03-23 | STEFANOVICH ROBERT | Chief Financial Officer | Sell | 1K | $8.18 | $9K | 279K |
| 2026-03-23 | SHELTON JERRELL | President, CEO | Exercise or conversion | 25K | $1.87 | $47K | 1.1M |
| 2026-03-23 | SHELTON JERRELL | President, CEO | Sell | 3K | $8.18 | $24K | 1.1M |
| 2026-03-23 | Sawicki Mark W | Chief Scientific Officer | Sell | 1K | $8.18 | $11K | 102K |
| 2026-03-16 | STEFANOVICH ROBERT | Chief Financial Officer | Sell | 3K | $8.00 | $22K | 280K |
| 2026-03-16 | ZECCHINI EDWARD J | See Remarks | Sell | 2K | $8.00 | $16K | 110K |
| 2026-03-16 | SHELTON JERRELL | President, CEO | Sell | 8K | $8.00 | $63K | 1.1M |
| 2026-03-16 | Sawicki Mark W | Chief Scientific Officer | Sell | 3K | $8.00 | $26K | 104K |
| 2026-03-14 | STEFANOVICH ROBERT | Chief Financial Officer | Grant | 27K | $0.00 | $0 | 283K |
| 2026-03-14 | ZECCHINI EDWARD J | See Remarks | Grant | 21K | $0.00 | $0 | 112K |
| 2026-03-14 | Sawicki Mark W | Chief Scientific Officer | Grant | 23K | $0.00 | $0 | 107K |
| 2026-03-12 | STEFANOVICH ROBERT | Chief Financial Officer | Sell | 39K | $7.76 | $300K | 256K |
| 2026-03-12 | STEFANOVICH ROBERT | Chief Financial Officer | Exercise or conversion | 87K | $1.87 | $163K | 294K |
| 2025-12-10 | Mandalam Ramkumar | Director | Sell | 12K | $9.99 | $116K | 81K |
| 2025-09-11 | Hariri Robert J | Director | Sell | 25K | $9.71 | $243K | 51K |
| 2025-09-11 | Hariri Robert J | Director | Exercise or conversion | 50K | $2.66 | $133K | 76K |
| 2025-08-22 | Hariri Robert J | Director | Sell | 5K | $8.60 | $43K | 26K |
| 2025-08-19 | STEFANOVICH ROBERT | Chief Financial Officer | Sell | 9K | $8.67 | $81K | 207K |
| 2025-08-19 | STEFANOVICH ROBERT | Chief Financial Officer | Exercise or conversion | 26K | $3.07 | $80K | 217K |
| 2025-08-13 | SHELTON JERRELL | President, CEO | Exercise or conversion | 25K | $5.00 | $125K | 1.1M |
| 2025-07-31 | SHELTON JERRELL | President, CEO | Exercise or conversion | 25K | $5.00 | $125K | 1.0M |
| 2025-07-24 | SHELTON JERRELL | President, CEO | Exercise or conversion | 25K | $5.00 | $125K | 1.0M |
| 2025-07-22 | Mandalam Ramkumar | Director | Sell | 41K | $7.24 | $295K | 92K |
| 2025-07-22 | Mandalam Ramkumar | Director | Exercise or conversion | 60K | $3.07 | $184K | 133K |
| 2025-07-18 | SHELTON JERRELL | President, CEO | Exercise or conversion | 25K | $5.00 | $125K | 987K |
| 2025-07-08 | SHELTON JERRELL | President, CEO | Exercise or conversion | 25K | $5.00 | $125K | 962K |
| 2025-06-25 | SHELTON JERRELL | President, CEO | Exercise or conversion | 25K | $5.00 | $125K | 937K |
| 2025-06-24 | SHELTON JERRELL | President, CEO | Sell | 16K | $7.06 | $115K | 912K |
| 2025-06-24 | SHELTON JERRELL | President, CEO | Exercise or conversion | 16K | $5.00 | $82K | 929K |
| 2025-06-24 | Mandalam Ramkumar | Director | Sell | 13K | $7.01 | $93K | 73K |
| 2025-06-24 | Mandalam Ramkumar | Director | Exercise or conversion | 20K | $3.07 | $61K | 86K |
| 2025-06-20 | SHELTON JERRELL | President, CEO | Sell | 69K | $6.47 | $448K | 912K |
| 2025-06-20 | SHELTON JERRELL | President, CEO | Exercise or conversion | 69K | $5.00 | $346K | 982K |
| 2025-06-18 | SHELTON JERRELL | President, CEO | Sell | 119K | $6.81 | $813K | 912K |
| 2025-06-18 | SHELTON JERRELL | President, CEO | Exercise or conversion | 119K | $5.00 | $596K | 1.0M |
| 2025-06-17 | SHELTON JERRELL | President, CEO | Sell | 151K | $6.81 | $1.0M | 912K |
| 2025-06-17 | SHELTON JERRELL | President, CEO | Exercise or conversion | 151K | $5.00 | $757K | 1.1M |
| 2025-06-17 | SHELTON JERRELL | President, CEO | Exercise or conversion | 50K | $5.00 | $250K | 912K |
| 2025-06-13 | Mandalam Ramkumar | Director | Sell | 624 | $6.80 | $4K | 66K |
| 2025-06-12 | Mandalam Ramkumar | Director | Sell | 2K | $7.01 | $13K | 67K |
| 2025-06-11 | Mandalam Ramkumar | Director | Sell | 8K | $7.06 | $58K | 69K |
| 2025-06-10 | ZECCHINI EDWARD J | Chief Digital and Tech Officer | Exercise or conversion | 75K | $3.07 | $230K | 142K |
| 2025-06-10 | ZECCHINI EDWARD J | Chief Digital and Tech Officer | Sell | 52K | $6.85 | $353K | 90K |
| 2025-06-09 | Mandalam Ramkumar | Director | Sell | 6K | $7.06 | $40K | 77K |
| 2025-06-06 | BADDOUR LINDA | Director | Grant | 23K | $0.00 | $0 | 58K |
| 2025-06-06 | Hariri Robert J | Director | Grant | 23K | $0.00 | $0 | 31K |
| 2025-06-06 | Mandalam Ramkumar | Director | Grant | 23K | $0.00 | $0 | 83K |
| 2025-06-06 | HANCOCK DANIEL M | Director | Grant | 23K | $0.00 | $0 | 59K |
| 2025-06-04 | SHELTON JERRELL | President, CEO | Exercise or conversion | 50K | $5.00 | $250K | 862K |
| 2025-06-02 | SHELTON JERRELL | President, CEO | Exercise or conversion | 50K | $5.00 | $250K | 812K |
| 2025-05-28 | Hariri Robert J | Director | Sell | 13K | $6.10 | $76K | 8K |
| 2025-03-24 | SHELTON JERRELL | President, CEO | Sell | 3K | $6.94 | $21K | 762K |
| 2025-03-24 | STEFANOVICH ROBERT | Chief Financial Officer | Sell | 1K | $6.94 | $7K | 190K |
| 2025-03-24 | Sawicki Mark W | Chief Scientific Officer | Sell | 1K | $6.94 | $9K | 84K |
| 2025-03-17 | SHELTON JERRELL | President, CEO | Sell | 5K | $6.29 | $29K | 765K |
| 2025-03-17 | Sawicki Mark W | Chief Scientific Officer | Sell | 2K | $6.29 | $13K | 85K |
| 2025-03-17 | STEFANOVICH ROBERT | Chief Financial Officer | Sell | 2K | $6.29 | $10K | 191K |
| 2025-03-17 | ZECCHINI EDWARD J | Chief Digital and Tech Officer | Sell | 1K | $6.29 | $7K | 67K |
| 2025-03-14 | SHELTON JERRELL | President, CEO | Grant | 30K | $0.00 | $0 | 770K |
| 2025-03-14 | Sawicki Mark W | Chief Scientific Officer | Grant | 9K | $0.00 | $0 | 88K |
| 2025-03-14 | STEFANOVICH ROBERT | Chief Financial Officer | Grant | 10K | $0.00 | $0 | 193K |
| 2025-03-14 | ZECCHINI EDWARD J | Chief Digital and Tech Officer | Grant | 8K | $0.00 | $0 | 68K |
| 2025-03-10 | STEFANOVICH ROBERT | Chief Financial Officer | Sell | 1K | $4.88 | $6K | 183K |
| 2025-03-10 | SHELTON JERRELL | President, CEO | Sell | 4K | $4.88 | $20K | 740K |
| 2025-03-10 | Sawicki Mark W | Chief Scientific Officer | Sell | 2K | $4.88 | $8K | 79K |
| 2025-03-09 | STEFANOVICH ROBERT | Chief Financial Officer | Exercise or conversion | 3K | $0.00 | $0 | 184K |
| 2025-03-09 | SHELTON JERRELL | President, CEO | Exercise or conversion | 8K | $0.00 | $0 | 744K |
| 2025-03-09 | Sawicki Mark W | Chief Scientific Officer | Exercise or conversion | 3K | $0.00 | $0 | 80K |
| 2024-12-11 | STEFANOVICH ROBERT | Chief Financial Officer | Exercise or conversion | 53K | $4.80 | $256K | 182K |
| 2024-12-02 | Mandalam Ramkumar | Director | Exercise or conversion | 11K | $4.80 | $52K | 67K |
| 2024-12-02 | Mandalam Ramkumar | Director | Sell | 7K | $7.46 | $55K | 59K |
| 2024-11-22 | SHELTON JERRELL | President, CEO | Sell | 23K | $6.47 | $148K | 736K |
| 2024-11-22 | SHELTON JERRELL | President, CEO | Exercise or conversion | 27K | $4.80 | $129K | 759K |
| 2024-11-21 | SHELTON JERRELL | President, CEO | Sell | 50K | $6.51 | $326K | 732K |
| 2024-11-21 | SHELTON JERRELL | President, CEO | Exercise or conversion | 59K | $4.80 | $284K | 782K |
| 2024-11-21 | Hariri Robert J | Director | Sell | 3K | $6.48 | $16K | 21K |
| 2024-11-20 | SHELTON JERRELL | President, CEO | Exercise or conversion | 60K | $4.80 | $288K | 773K |
| 2024-11-20 | SHELTON JERRELL | President, CEO | Sell | 50K | $6.65 | $333K | 723K |
| 2024-11-19 | SHELTON JERRELL | President, CEO | Exercise or conversion | 60K | $4.80 | $290K | 763K |
| 2024-11-19 | SHELTON JERRELL | President, CEO | Sell | 50K | $6.78 | $339K | 713K |
| 2024-11-18 | SHELTON JERRELL | President, CEO | Exercise or conversion | 60K | $4.80 | $289K | 752K |
| 2024-11-18 | SHELTON JERRELL | President, CEO | Sell | 50K | $6.73 | $337K | 702K |
| 2024-08-19 | Hariri Robert J | Director | Sell | 1K | $9.47 | $9K | 23K |
| 2024-08-16 | Hariri Robert J | Director | Sell | 1K | $9.00 | $9K | 24K |
| 2024-08-14 | Hariri Robert J | Director | Sell | 1K | $8.40 | $8K | 25K |
| 2024-08-02 | Mandalam Ramkumar | Director | Sell | 4K | $8.04 | $34K | 56K |
| 2024-08-02 | Mandalam Ramkumar | Director | Exercise or conversion | 4K | $5.04 | $21K | 60K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON7 Form 144 notices on file for CYRX worth $4.5M at the prices reported; 1 in the last 90 days worth $427K. Latest: JERRELL W SHELTON filed on 2026-08-11 to sell 28,800 shares ($427K) from 2026-08-11.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-08-11 | JERRELL W SHELTONDirector, Officer | 29K | $427K | 0.057% | 2026-08-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-11 | EDWARD ZECCHINIOfficer | 34K | $486K | 0.067% | 2026-06-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-10 | EDWARD ZECCHINIOfficer | 1K | $21K | 0.003% | 2026-06-10 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-08 | RAMKUMAR MANDALAMDirector | 23K | $358K | 0.046% | 2026-06-08 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-03 | STEFANOVICH ROBERTOfficer | 169K | $2.8M | 0.336% | 2026-06-04 | Edward Jones |
| 2026-03-12 | ROBERT S. STEFANOVICHOfficer | 39K | $300K | 0.078% | 2026-03-12 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-10 | RAMKUMAR MANDALAMDirector | 12K | $116K | 0.023% | 2025-12-10 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON3 holders report 5% or more of CYRX in their latest filing, all on Schedule 13G (passive). The largest reported stake is Cadian Capital Management, LP at 5.8% of the class (2,920,681 shares), filed 2026-08-14 for an event on 2026-06-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-14 | 13G/Ano. 3 | Cadian Capital Management, LPinvestment adviser, partnership | 2.9M | 5.8% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 3 | Cadian Capital Management GP, LLCother entity, parent holding company | 2.9M | 5.8% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 3 | ERIC BANNASCHindividual, parent holding company | 2.9M | 5.8% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 1 | Morgan Stanleyparent holding company, corporation | 2.2M | 4.5% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 1 | Morgan Stanley Capital Services LLCbroker-dealer, corporation | 2.2M | 4.3% | 2026-06-30 |
| 2026-07-29 | 13G/Ano. 2 | Millennium Group Management LLCother entity | 1.7M | 3.4% | 2026-06-30 |
| 2026-07-29 | 13G/Ano. 2 | Millennium Management LLCother entity | 1.7M | 3.4% | 2026-06-30 |
| 2026-07-29 | 13G/Ano. 2 | Israel A. Englanderindividual | 1.7M | 3.4% | 2026-06-30 |
| 2026-07-29 | 13G/Ano. 2 | Integrated Core Strategies (US) LLCother entity | 1.6M | 3.1% | 2026-06-30 |
| 2026-03-26 | 13G/Ano. 7 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2026-02-17 | 13G/Ano. 9 | Brown Capital Management, LLCinvestment adviser | 1.1M | 2.2% | 2025-12-31 |
13F holders
Tracked managers holding CYRX at their latest 13F. JSON6 of the 30 tracked managers held CYRX at their latest 13F, $49.4M in total at quarter-end prices. Millennium Management is the largest at $27.1M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 4 added shares and 2 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Millennium Management | 2026-06-30 | 1.7M | $27.1M | 0.01% | -1.2M |
| D. E. Shaw & Co. | 2026-06-30 | 480K | $7.5M | 0.00% | +321K |
| AQR Capital Management | 2026-06-30 | 400K | $6.3M | 0.00% | +64K |
| Renaissance Technologies | 2026-06-30 | 372K | $5.8M | 0.01% | +4K |
| Citadel Advisors | 2026-06-30 | 156K | $2.4M | 0.00% | -27K |
| Two Sigma Investments | 2026-06-30 | 14K | $225K | 0.00% | new |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
Cryoport in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Cryoport (CYRX), SEC CIK 1124524, listed on Nasdaq, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-24.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-08-11.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-14.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-06.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-08-11.JSON and CSV
- Company record
- EDGAR filing index for CIK 1124524Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as pharmaceutical preparations
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
Datasets
Frequently Asked Questions
How much of CYRX is sold short?
2,532,755 shares were held short at the 2026-10-15 settlement, 3.1 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is CYRX's daily short volume?
On 2026-11-02, 124,887 of the 381,842 CYRX shares reported to FINRA were sold short, 32.7% of the day's reported volume. Short volume is a flow for one day, not a position.
Does CYRX have fails to deliver?
The SEC's latest file shows 645 CYRX shares failed to deliver at settlement 2026-09-24. Fails are reported per settlement date and published twice a month with a lag.
Are CYRX insiders buying or selling?
Insiders at CYRX reported 1 open-market sell worth $429K in the last 90 days and no open-market buys. Latest filing: SHELTON JERRELL (President, CEO) on 2026-08-11.
Have CYRX insiders filed to sell?
7 Form 144 notices on file for CYRX worth $4.5M at the prices reported; 1 in the last 90 days worth $427K. Latest: JERRELL W SHELTON filed on 2026-08-11 to sell 28,800 shares ($427K) from 2026-08-11.
Who owns 5% or more of CYRX?
3 holders report 5% or more of CYRX in their latest filing, all on Schedule 13G (passive). The largest reported stake is Cadian Capital Management, LP at 5.8% of the class (2,920,681 shares), filed 2026-08-14 for an event on 2026-06-30.
Which tracked 13F managers own CYRX?
6 of the 30 tracked 13F managers held CYRX shares at their latest filing, $49.4M in all. The largest: Izzy Englander's Millennium Management (1.7M shares, $27.1M), D. E. Shaw & Co. (480K shares, $7.5M), Cliff Asness's AQR Capital Management (400K shares, $6.3M), Renaissance Technologies (372K shares, $5.8M), Ken Griffin's Citadel Advisors (156K shares, $2.4M), Two Sigma Investments (14K shares, $225K).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.